Robert Califf Headshot
Report a problem with this profile
[email protected]

Robert Califf    

Former Deputy Commissioner, Medical Products and Tobacco, U.S. Food and Drug Administration

Robert Califf is deputy commissioner for medical products and tobacco for the Food and Drug Administration (FDA), where he provides executive leadership for four centers and the Office of Special Medical Programs. Before joining FDA, Califf was a professor of medicine, vice chancellor for clinical and translational research, and director of two institutes at Duke University. While at Duke, he led major initiatives to improve clinical research and served as principal investigator for two large projects. A frequently cited bioscience author, he has more than 1,200 peer-reviewed publications. Califf has served on committees for the Institute of Medicine, FDA, and the National Institutes of Health. He graduated from Duke University School of Medicine and completed a residency in internal medicine and a fellowship in cardiology.

Robert M. Califf, MD, MACC, was the Commissioner of Food and Drugs from February 2016 to January 2017. * As the top official of the Food and Drug Administration, Dr. Califf was committed to strengthening programs and policies that enable the agency to carry out its mission to protect and promote the public health. Previously, Dr. Califf served as the FDA’s Deputy Commissioner for Medical Products and Tobacco from February 2015 until his appointment as Commissioner in February 2016.

Prior to joining the FDA, Dr. Califf was a professor of medicine and vice chancellor for clinical and translational research at Duke University. He also served as director of the Duke Translational Medicine Institute and founding director of the Duke Clinical Research Institute. A nationally and internationally recognized expert in cardiovascular medicine, health outcomes research, healthcare quality, and clinical research, Dr. Califf has led many landmark clinical trials and is one of the most frequently cited authors in biomedical science, with more than 1,200 publications in the peer-reviewed literature.

Dr. Califf became a Member of the National Academy of Medicine (formerly known as the Institute of Medicine (IOM)) in 2016, one of the highest honors in the fields of health and medicine. Dr. Califf has served on numerous IOM committees, and he has served as a member of the FDA Cardiorenal Advisory Panel and FDA Science Board's Subcommittee on Science and Technology. Dr. Califf has also served on the Board of Scientific Counselors for the National Library of Medicine, as well as on advisory committees for the National Cancer Institute, the National Heart, Lung, and Blood Institute, the National Institute of Environmental Health Sciences and the Council of the National Institute on Aging.

While at Duke, Dr. Califf led major initiatives aimed at improving methods and infrastructure for clinical research, including the Clinical Trials Transformation Initiative (CTTI), a public-private partnership co-founded by the FDA and Duke. He also served as the principal investigator for Duke's Clinical and Translational Science Award and the NIH Health Care Systems Research Collaboratory coordinating center.

Dr. Califf is a graduate of Duke University School of Medicine. He completed a residency in internal medicine at the University of California, San Francisco and a fellowship in cardiology at Duke.

  • Dr. Stephen Ostroff served as Acting Commissioner from April 7, 2015 to February 22, 2016, and he was reappointed as Acting Commissioner on January 20, 2017.


Duke's Rob Califf Named FDA Deputy Commissioner - Forbes

FDA Commissioner Margaret Hamburg announced this morning that Robert Califf, MD, will be joining the agency in February as Deputy Commissioner of the  ...

Obama Nominates Duke Researcher Robert Califf to Lead FDA ...

President Barack Obama nominated Robert Califf as the next commissioner of the U.S. Food and Drug Administration, selecting a well-respected Duke ...

Related Speakers View all

More like Robert